Lumenis Ltd., the world's largest medical laser company, announced today they will be focusing their attention at this year's AAO-HNS annual meeting in San Diego, California, on an educational event to discuss different treatment options for laryngeal cancer. In addition, two new laser systems for the physician-office and surgery center will be introduced.
A Breakfast Symposium will be held on Tuesday, October 6th, 2009, entitled "Controversies in Management of Laryngeal Cancer: The Emerging Roles of Endoscopic Resection and Radiation Therapy" and will be moderated by Dr. Mark S. Courey of University of California, San Francisco, Director of the Division of Laryngology. Two laser surgeons and radiation oncologists will engage in a constructive debate about various treatment modalities.
"We are pleased to provide an educational forum in this important arena," said Mr. Dov Ofer, Lumenis' Chief Executive Officer. "Transoral Laser Microsurgery (TLM) and Radiation Therapy are major options in the physician's armamentarium to manage laryngeal and oral-pharyngeal cancers. We look forward to the panel's discussion on the latest findings which indicate that automated and robotic CO2 laser systems achieve superior results."
"New and advanced laser systems have made much of the difference," commented Dr. Paul Castellanos, Associate Professor of Surgery, Laryngology-Bronchoesophagology, University of Alabama at Birmingham. "The UltraPulse SurgiTouch CO2 Laser with the Digital AcuBlade (DAB) microsurgery system allows me to achieve unparalleled levels of precision, low thermal damage and treatment reproducibility. The DAB automatically carries out laser incisions and ablations that allow me to recognize margins better, which is especially important in TLM for airway stenosis (narrowing) where collateral tissue damage is a matter of life and death."